Table 1.

Details of discarded diagnostic samples from patients used in the study. The numbers in parentheses indicate the number of patients in each group

Sample set	Quality	Survival	Analysis
EBOV-positive samples for RNA-seq (n = 138)	Poor quality: removed from analysis (n = 26)	N/A	N/A
	Good-quality samples (n = 112)	Survived (n = 24)	Transcriptomic analysis for differential gene expression and classifier generation
		Fatal (n= 88)
EBOV-positive and malaria-negative (n = 37)	N/A	Fatal (n = 20)	Flow analysis
		Survived (n = 17)
Febrile and EBOV-negative (n = 10)	N/A	N/A
Malaria-positive and EBOV-negative (n = 5)	N/A	N/A
EBOV-positive sample with similar Ct values (n = 20)	Good quality (n = 20)	Survived (n = 10)	Validation dataset for differential gene expression and classifiers
		Fatal (n = 10)
Convalescent EBOV-negative (n = 16)	Good quality (n = 16)	Survived (n = 16)	Control for EBOV-positive samples
Healthy controls (n = 6)	Good quality (n = 6)	Never infected (n = 6)	Comparator for convalescent samples